One area of the market that has been gaining steam: biotech stocks. A flurry of deals, FDA approvals, and recent innovations in the biotech space have seen the Nasdaq Biotechnology Index exhibit a quarterly uptick of 24%, easily beating the S&P 500’s 8.3% quarterly gain. The recent surge has helped the sector close the gap on the S&P 500’s stellar 2019, and a 27% year-to-date increase brings it into the realm of the major index’s 29% yearly gain.While earlier in the year, the sector as a whole may have lagged behind the general market trend, the biotech industry’s infamous volatility …read more
Source:: Yahoo Finance
